Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

Dominant mechanisms of primary resistance differ from dominant mechanisms of secondary resistance to targeted therapies

(2016) Ksenija Asić   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

(2015) D. P. Steensma et al.   BLOOD

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

(2015) R. D. Morin et al.   CLINICAL CANCER RESEARCH

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma

(2015) Sylvain Mareschal et al.   GENES CHROMOSOMES & CANCER

Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder

(2015) Heinz Läubli et al.   LEUKEMIA & LYMPHOMA

Clinical, Morphologic, Phenotypic, and Genetic Evidence of Cyclin D1-positive Diffuse Large B-cell Lymphomas With CYCLIN D1 Gene Rearrangements

(2014) Darius Juskevicius et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Deep Sequencing Reveals Lack of a Clonal Relationship Between a Metachronous Classical Hodgkin and Diffuse Large B-Cell Lymphoma

(2014) Imran N. Siddiqi et al.   Clinical Lymphoma Myeloma & Leukemia

Genetics of Follicular Lymphoma Transformation

(2014) Laura Pasqualucci et al.   Cell Reports

Successive B-Cell Lymphomas Mostly Reflect Recurrences Rather Than Unrelated Primary Lymphomas

(2013) Willemina R. R. Geurts-Giele et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

(2013) Jessica Okosun et al.   NATURE GENETICS

IgBLAST: an immunoglobulin variable domain sequence analysis tool

(2013) Jian Ye et al.   NUCLEIC ACIDS RESEARCH

Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin

(2012) Chezi Ganzel et al.   EXPERIMENTAL HEMATOLOGY

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

(2012) C. Visco et al.   HAEMATOLOGICA

Clonal Relationship of Classical Hodgkin Lymphoma and Its Recurrences

(2011) Ellen C. Obermann et al.   CLINICAL CANCER RESEARCH

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

(2011) J. W. Friedberg   Hematology-American Society of Hematology Education Program

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

(2010) Christian Gisselbrecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

(2009) Sabine Nagel et al.   EXPERIMENTAL HEMATOLOGY

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-κB in peripheral T-cell lymphomas and is associated with clinical outcome

(2009) Javier Briones et al.   HISTOPATHOLOGY